DME Capital Management »

Neubase Therapeutics shares owned by DME Capital Management

Quarter-by-quarter ownership of Neubase Therapeutics (NBSE) shares owned by DME Capital Management from 13F filings

Historical chart of DME Capital Management investment in Neubase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neubase Therapeutics held by DME Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neubase Therapeutics by DME Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $61k 136k 0.45

More positions owned by DME Capital Management

Green Brick Partners (GRBK)
Brighthouse Finl (BHF)
Kyndryl Hldgs Common Stock (KD)
Consol Energy (CEIX)
Alight Com Cl A (ALIT)
Tenet Healthcare Corp Com New (THC)
ODP Corp. (ODP)
Penn National Gaming (PENN)
Livanova SHS (LIVN)
Teck Resources CL B (TECK)
Viatris (VTRS)
Graphic Packaging Holding Company (GPK)
Spdr Gold Tr Gold Shs (GLD)
Hp (HPQ)
Dht Holdings Shs New (DHT)

View all positions for DME Capital Management

Top funds holding Neubase Therapeutics

DME Capital Management
Greenlight Capital
Point72 Asset Management
Carnegie Mellon University
Vanguard Group
Kestra Advisory Services
Springbok Capital Management
Geode Capital Management
UBS Group
Tower Research Capital
Cubist Systematic Strategies
Bank of America Corporation
First Manhattan
Royal Bank of Canada
Wells Fargo & Company

View all funds holding Neubase Therapeutics